CSL Limited to invest $1.5 b in U.S. manufacturing of plasma‐derived therapies:

CSL Limited to invest $1.5 b in U.S. manufacturing of plasma‐derived therapies

The biotech company announced a major expansion in the U.S., creating jobs and strengthening domestic pharmaceutical manufacturing for rare/serious diseases.

Why it matters: Health industry growth ties into job creation, supply-chain resilience and advanced medicine access. #BTC90kBreakingPoint #TrumpBitcoinEmpire #ProjectCrypto $BTC

BTC

91,587.44

+2.14%

$ETH

ETH

3,135.38

+2.90%

$BNB

BNB

904.17

+0.97%